These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15637515)

  • 1. Screening and detection of ovarian cancer.
    Breedlove G; Busenhart C
    J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer screening: a look at the evidence.
    Fields MM; Chevlen E
    Clin J Oncol Nurs; 2006 Feb; 10(1):77-81. PubMed ID: 16482731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress report on ovarian cancer screening. Scientists are making headway in detecting ovarian cancer at an earlier stage.
    Harv Womens Health Watch; 2010 Apr; 17(8):1-3. PubMed ID: 20506601
    [No Abstract]   [Full Text] [Related]  

  • 6. HE4 in ovarian cancer: from discovery to clinical application.
    Montagnana M; Danese E; Giudici S; Franchi M; Guidi GC; Plebani M; Lippi G
    Adv Clin Chem; 2011; 55():1-20. PubMed ID: 22126021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteins' promise--progress and challenges in ovarian cancer proteomics.
    Koehn H; Oehler MK
    Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing ovarian cancer screening.
    Goozner M
    J Natl Cancer Inst; 2010 Aug; 102(15):1112-3. PubMed ID: 20668268
    [No Abstract]   [Full Text] [Related]  

  • 9. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer. The most lethal gynecologic malignancy.
    Brucks JA
    Nurs Clin North Am; 1992 Dec; 27(4):835-45. PubMed ID: 1448359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early detection and preoperative diagnosis of ovarian carcinoma].
    Kainz C
    Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACR appropriateness criteria© ovarian cancer screening.
    Brown DL; Andreotti RF; Lee SI; Dejesus Allison SO; Bennett GL; Dubinsky T; Glanc P; Horrow MM; Lev-Toaff AS; Horowitz NS; Podrasky AE; Scoutt LM; Zelop CM
    Ultrasound Q; 2010 Dec; 26(4):219-23. PubMed ID: 21084936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
    McLemore MR; Aouizerat B
    Biol Res Nurs; 2005 Apr; 6(4):262-7. PubMed ID: 15788735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cancer antigen 125 (CA 125) during treatment and follow-up of patients with ovarian cancer.
    de Bruijn HW; van der Zee AG; Aalders JG
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):8-13. PubMed ID: 9090475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for ovarian cancer].
    Bjørge T; Dørum A; Tropé CG
    Tidsskr Nor Laegeforen; 2000 May; 120(12):1444-8. PubMed ID: 10851943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the detection of ovarian cancer: a review.
    Blend MJ; Ostrowski GJ
    J Am Osteopath Assoc; 1994 Apr; 94(4):305-18. PubMed ID: 8026999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biomarker in gynecologic malignancies].
    Isonishi S
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1003-7. PubMed ID: 15272576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer.
    Gogoi R; Srinivasan S; Fishman DA
    Expert Rev Mol Diagn; 2006 Jul; 6(4):627-37. PubMed ID: 16824035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.